TRCT
EDSA icon

Tower Research Capital (TRC)’s Edesa Biotech EDSA Stock Holding History

Tower Research Capital (TRC)’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
1,230
+723
+143% +$6.52K ﹤0.01% 3996
2026
Q1 		$2.65K Sell
507
-2,047
-80% -$6.14K ﹤0.01% 4443
2025
Q4 		$3.63K Buy
2,554
+1,275
+100% +$2.5K ﹤0.01% 4337
2025
Q3 		$3.16K Sell
1,279
-1,064
-45% -$2.46K ﹤0.01% 4541
2025
Q2 		$4.76K Buy
2,343
+1,151
+97% +$2.45K ﹤0.01% 4272
2025
Q1 		$2.91K Sell
1,192
-2,246
-65% -$4.84K ﹤0.01% 4489
2024
Q4 		$5.78K Buy
3,438
+2,422
+238% +$6.74K ﹤0.01% 4244
2024
Q3 		$4.52K Sell
1,016
-1,430
-58% -$6.5K ﹤0.01% 4516
2024
Q2 		$10.5K Buy
2,446
+372
+18% +$1.66K ﹤0.01% 4147
2024
Q1 		$8.69K Buy
2,074
+510
+33% +$2.38K ﹤0.01% 3976
2023
Q4 		$7.15K Buy
1,564
+347
+29% +$1.32K ﹤0.01% 4651
2023
Q3 		$5.38K Hold
1,217
– – ﹤0.01% 4728
2023
Q2 		$6.91K Sell
1,217
-160
-12% -$1.06K ﹤0.01% 4645
2023
Q1 		$9K Buy
1,377
+456
+50% +$4.76K ﹤0.01% 4480
2022
Q4 		$14K Sell
921
-809
-47% -$6.02K ﹤0.01% 3498
2022
Q3 		$11K Buy
1,730
+1,229
+245% +$15.1K ﹤0.01% 4433
2022
Q2 		$6K Buy
501
+75
+18% +$1.1K ﹤0.01% 4916
2022
Q1 		$9K Buy
426
+380
+826% +$10.5K ﹤0.01% 4445
2021
Q4 		$2K Sell
46
-422
-90% -$20.2K ﹤0.01% 5614
2021
Q3 		$24K Buy
+468
New +$18.2K ﹤0.01% 3555
2016
Q4 		– Sell
-2
Closed -$1K – 3931
2016
Q3 		$1K Sell
2
-1
-33% -$839 ﹤0.01% 3281
2016
Q2 		$3K Sell
3
-2
-40% -$2.06K ﹤0.01% 3677
2016
Q1 		$7K Buy
+5
New +$8.75K ﹤0.01% 2351
2015
Q4 		– Hold
0
– – – 4595

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Tower Research Capital (TRC)'s EDSA Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Edesa Biotech (EDSA) stake by 143% in Q2 2026, buying an estimated $6.52K and bringing the position to 1,230 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3996.

Tower Research Capital (TRC) first reported a position in EDSA in Q1 2016 and has held it in 23 quarters since. The position peaked at $24K in Q3 2021. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Tower Research Capital (TRC) held 1,230 shares of Edesa Biotech worth $10K as of Q2 2026.
  • Tower Research Capital (TRC) bought 723 Edesa Biotech shares in Q2 2026, an estimated $6.52K.
  • Edesa Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3996 holding.
  • Tower Research Capital (TRC) first reported a position in Edesa Biotech in Q1 2016 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Edesa Biotech position peaked at $24K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.